These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8023249)

  • 1. [HDR or LDR in gynecological brachytherapy?].
    Prager W
    Strahlenther Onkol; 1994 Jun; 170(6):368. PubMed ID: 8023249
    [No Abstract]   [Full Text] [Related]  

  • 2. HDR versus LDR gynecological brachytherapy revisited.
    Scalliet P; Gerbaulet A; Dubray B
    Radiother Oncol; 1993 Aug; 28(2):118-26. PubMed ID: 8248552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences with interstitial HDR afterloading therapy in genital and breast cancer.
    Jacobs H
    Sonderb Strahlenther Onkol; 1988; 82():258-62. PubMed ID: 3134722
    [No Abstract]   [Full Text] [Related]  

  • 4. HDR brachytherapy with improved accuracy using anatomically adapted treatment planning.
    Ragnhult I; Himmelmann A
    Sonderb Strahlenther Onkol; 1988; 82():90-3. PubMed ID: 3134733
    [No Abstract]   [Full Text] [Related]  

  • 5. HDR versus LDR gynaecological brachytherapy revisited.
    Jones B; Tan LT; Kingston R
    Radiother Oncol; 1994 Feb; 30(2):186. PubMed ID: 8184123
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gynecologic brachytherapy--from low-dose-rate to high-tech].
    Herrmann T; Christen N; Alheit HD
    Strahlenther Onkol; 1993 Mar; 169(3):141-51. PubMed ID: 8465248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
    Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model.
    Ling CC; Sahoo N; Leibel S; Anderson LL
    Radiother Oncol; 1992 Oct; 25(2):103-10. PubMed ID: 1438929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three brachytherapy gynecological intercavitary treatment planning systems.
    Concannon PJ; Mermis N; Nguyen L; Palmer MB
    Med Dosim; 2004; 29(2):115-7. PubMed ID: 15191758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Nucletron and ROCS brachytherapy treatment planning systems for LDR and HDR applications.
    Ho AK; Sibata CH; Shin KH
    Med Dosim; 1994; 19(3):147-9. PubMed ID: 7818754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
    Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
    Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDR in gynecological applications: dose and volume considerations.
    Orton CG
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1379-80; author reply 1381. PubMed ID: 2045312
    [No Abstract]   [Full Text] [Related]  

  • 15. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current methods in brachytherapy of female genital malignancies].
    Kanaev SV; Turkevich VG; Baranov SB
    Vopr Onkol; 1997; 43(1):47-53. PubMed ID: 9133086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracavitary brachytherapy with long and short-term afterloading technic in gynecology].
    Bauer M
    Gynakologe; 1987 Dec; 20(4):228-36. PubMed ID: 3325373
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point: why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?
    Davidson SE; Hendry JH; West CM
    Brachytherapy; 2009; 8(3):269-72. PubMed ID: 19643373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.